Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
Titel:
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
Auteur:
Feagan, Brian G. Schreiber, Stefan Afzali, Anita Rieder, Florian Hyams, Jeffrey Kollengode, Kanthi Pearlman, Jared Son, Vladimir Marta, Cecilia Wolf, Douglas C. D'Haens, Geert G.